Literature DB >> 8552113

Epidemiology and outcome of cervical dystonia (spasmodic torticollis) in Rochester, Minnesota.

D W Claypool1, D D Duane, D M Ilstrup, L J Melton.   

Abstract

The natural history of cervical dystonia (spasmodic torticollis) was investigated in a population-based study in Rochester, Minnesota. Eleven new cases were identified with onset during the 20-year period 1960-1979. The overall incidence rate was 1.2 per 100,000 person-years (95% confidence interval 0.5-1.9) with a female:male ratio of age-adjusted incidence rates of 3.6:1. A unitary etiology was not apparent: injury antedated onset in four of the 11 patients, whereas six had documented thyroid disease and four had diabetes. A family history of movement disorder was recorded for only one subject. Only one of the cases would have been classified as moderate in severity; the others were mild. In follow-up through 1993, progressive disability was noted in only two patients, and two others went into remission. Three cases of intracranial aneurysm were confirmed, two of which produced fatal subarachnoid hemorrahage. A third death was due to amyotrophic lateral sclerosis.

Entities:  

Mesh:

Year:  1995        PMID: 8552113     DOI: 10.1002/mds.870100513

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  11 in total

1.  Costs of treating dystonias and hemifacial spasm with botulinum toxin A.

Authors:  R C Dodel; A Kirchner; R Koehne-Volland; G Künig; A Ceballos-Baumann; M Naumann; A Brashear; H P Richter; T D Szucs; W H Oertel
Journal:  Pharmacoeconomics       Date:  1997-12       Impact factor: 4.981

Review 2.  Cervical dystonia pathophysiology and treatment options.

Authors:  M Velickovic; R Benabou; M F Brin
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 3.  Risk factors for the development of degenerative cervical myelopathy: a review of the literature.

Authors:  Guillaume Baucher; Jelena Taskovic; Lucas Troude; Granit Molliqaj; Aria Nouri; Enrico Tessitore
Journal:  Neurosurg Rev       Date:  2021-11-30       Impact factor: 3.042

4.  A metabolomic study of cervical dystonia.

Authors:  Chang Liu; Laura Scorr; Gamze Kilic-Berkmen; Adam Cotton; Stewart A Factor; Alan Freeman; ViLinh Tran; Ken Liu; Karan Uppal; Dean Jones; H A Jinnah; Yan V Sun
Journal:  Parkinsonism Relat Disord       Date:  2020-11-26       Impact factor: 4.891

Review 5.  Pain Relief in Cervical Dystonia with Botulinum Toxin Treatment.

Authors:  Carlos Henrique Ferreira Camargo; Lígia Cattai; Hélio Afonso Ghizoni Teive
Journal:  Toxins (Basel)       Date:  2015-06-23       Impact factor: 4.546

6.  Descriptive epidemiology of cervical dystonia.

Authors:  Giovanni Defazio; Joseph Jankovic; Jennifer L Giel; Spyridon Papapetropoulos
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2013-11-04

7.  A retrospective study to assess resource utilization in patients with cervical dystonia in the United Kingdom.

Authors:  Mireia Raluy-Callado; Sylvie Gabriel; Jérôme Dinet; Meng Wang; Radek Wasiak
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-09       Impact factor: 2.570

8.  A mixed treatment comparison to compare the efficacy and safety of botulinum toxin treatments for cervical dystonia.

Authors:  Yi Han; Andrea L Stevens; Khashayar Dashtipour; Robert A Hauser; Zoltan Mari
Journal:  J Neurol       Date:  2016-02-25       Impact factor: 4.849

9.  Selective peripheral denervation for cervical dystonia: long-term follow-up.

Authors:  A Tommy Bergenheim; Erik Nordh; Eva Larsson; Marwan I Hariz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-10-31       Impact factor: 10.154

10.  Disease Progression of Idiopathic Cervical Dystonia in Spite of Improvement After Botulinum Toxin Therapy.

Authors:  Harald Hefter; Isabelle Schomaecker; Max Schomaecker; Sara Samadzadeh
Journal:  Front Neurol       Date:  2020-11-12       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.